|
Glenmark gets final US FDA nod for asthma treatment drug
Moneycontrol.com … has received final approval from US Food and Drugs Administration for its abbreviated new drug application (ANDA) to market Montelukast Sodium tablets in 10 mg strength, which are used for the treatment for prophylaxis and chronic treatment of asthma. |
View full post on asthma – Google News